A potential osteoporosis target in the FAS ligand/FAS pathway of osteoblast to osteoclast signaling.
作者信息
Jones Daniel R
机构信息
Division of Natural Sciences, Indiana Wesleyan University, Marion, Indiana 46953, USA.
出版信息
Ann Transl Med. 2015 Aug;3(14):189. doi: 10.3978/j.issn.2305-5839.2015.07.01.
Abstract
摘要
相似文献
1
A potential osteoporosis target in the FAS ligand/FAS pathway of osteoblast to osteoclast signaling.成骨细胞向破骨细胞信号传导的FAS配体/FAS途径中的一个潜在骨质疏松症靶点。
Ann Transl Med. 2015 Aug;3(14):189. doi: 10.3978/j.issn.2305-5839.2015.07.01.
2
Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.成骨细胞通过Fas配体/FAS途径诱导破骨细胞凋亡是维持骨量所必需的。
Cell Death Differ. 2015 Oct;22(10):1654-64. doi: 10.1038/cdd.2015.14. Epub 2015 Mar 6.
3
[Apoptotic cells and related factors in ovariectomized rat osteoporosis model].去卵巢大鼠骨质疏松模型中的凋亡细胞及相关因子
Zhonghua Nei Ke Za Zhi. 2001 Feb;40(2):98-100.
4
Fas- and Mitochondria-Mediated Signaling Pathway Involved in Osteoblast Apoptosis Induced by AlCl.Fas 和线粒体介导的信号通路在 AlCl 诱导的成骨细胞凋亡中的作用
Biol Trace Elem Res. 2018 Jul;184(1):173-185. doi: 10.1007/s12011-017-1176-y. Epub 2017 Oct 12.
5
Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway.巨噬细胞移动抑制因子（MIF）抑制剂 4-IPP 通过抑制 NF-κB 信号通路抑制破骨细胞形成并促进成骨细胞分化。
FASEB J. 2019 Jun;33(6):7667-7683. doi: 10.1096/fj.201802364RR. Epub 2019 Mar 20.
6
Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.大戟因子 L1 通过调节细胞氧化还原状态抑制破骨细胞生成，并诱导破骨细胞中 Fas 介导的细胞凋亡。
Free Radic Biol Med. 2017 Nov;112:191-199. doi: 10.1016/j.freeradbiomed.2017.07.030. Epub 2017 Jul 31.
7
WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.WHI-131 促进成骨细胞分化，防止破骨细胞形成和吸收在小鼠。
J Bone Miner Res. 2016 Feb;31(2):403-15. doi: 10.1002/jbmr.2612. Epub 2015 Aug 29.
8
Osteoclast apoptosis: the role of Fas in vivo and in vitro.破骨细胞凋亡：Fas在体内和体外的作用
Endocrinology. 2003 Dec;144(12):5545-55. doi: 10.1210/en.2003-0296. Epub 2003 Aug 22.
9
10
Live imaging of osteoclast inhibition by bisphosphonates in a medaka osteoporosis model.在青鳉骨质疏松模型中对双膦酸盐抑制破骨细胞的实时成像。
Dis Model Mech. 2016 Feb;9(2):155-63. doi: 10.1242/dmm.019091. Epub 2015 Dec 24.
引用本文的文献
1
Expression of osteogenic factors in FasL-deficient calvarial cells.成骨因子在 FasL 缺陷型颅骨细胞中的表达。
Physiol Res. 2023 Mar 8;72(1):117-121. doi: 10.33549/physiolres.934945. Epub 2022 Dec 22.
2
Impact of FasL Stimulation on Sclerostin Expression and Osteogenic Profile in IDG-SW3 Osteocytes.FasL刺激对IDG-SW3骨细胞中硬化蛋白表达和成骨特性的影响。
Biology (Basel). 2021 Aug 7;10(8):757. doi: 10.3390/biology10080757.
3
A Whole-Genome Sequencing Association Study of Low Bone Mineral Density Identifies New Susceptibility Loci in the Phase I Qatar Biobank Cohort.一项低骨密度的全基因组测序关联研究在卡塔尔生物样本库队列一期中发现了新的易感基因座。
J Pers Med. 2021 Jan 7;11(1):34. doi: 10.3390/jpm11010034.
4
Analysis of early stage osteonecrosis of the human femoral head and the mechanism of femoral head collapse.早期股骨头坏死的分析及股骨头塌陷的机制。
Int J Biol Sci. 2018 Jan 14;14(2):156-164. doi: 10.7150/ijbs.18334. eCollection 2018.
5
Is osteoporosis an autoimmune mediated disorder?骨质疏松症是一种自身免疫介导的疾病吗？
Bone Rep. 2017 Oct 16;7:121-131. doi: 10.1016/j.bonr.2017.10.003. eCollection 2017 Dec.
本文引用的文献
1
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation.单核苷酸多态性与心脏移植后免疫抑制剂治疗的疗效和安全性的关联
Pharmacogenomics. 2015;16(9):971-9. doi: 10.2217/pgs.15.39. Epub 2015 Jun 24.
2
Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis.硬骨素抑制：一种治疗骨质疏松症的新型治疗方法。
Int J Womens Health. 2015 Jun 2;7:565-80. doi: 10.2147/IJWH.S73244. eCollection 2015.
3
New antiresorptive therapies for postmenopausal osteoporosis.绝经后骨质疏松症的新型抗吸收疗法。
J Menopausal Med. 2015 Apr;21(1):1-11. doi: 10.6118/jmm.2015.21.1.1. Epub 2015 Apr 27.
4
Omentin Polymorphism and its Relations to Bone Mineral Density in Women.网膜素多态性及其与女性骨密度的关系。
Arch Med Res. 2015 Apr;46(3):173-80. doi: 10.1016/j.arcmed.2015.03.012. Epub 2015 May 14.
5
Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.成骨细胞通过Fas配体/FAS途径诱导破骨细胞凋亡是维持骨量所必需的。
Cell Death Differ. 2015 Oct;22(10):1654-64. doi: 10.1038/cdd.2015.14. Epub 2015 Mar 6.
6
Infection and medication-related osteonecrosis of the jaw.感染和药物相关的颌骨坏死。
J Dent Res. 2015 Apr;94(4):534-9. doi: 10.1177/0022034515572021. Epub 2015 Feb 20.
7
Bone disease in multiple myeloma: pathophysiology and management.多发性骨髓瘤中的骨病：病理生理学与管理
Cancer Growth Metastasis. 2014 Aug 10;7:33-42. doi: 10.4137/CGM.S16817. eCollection 2014.
8
Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis.地诺单抗在绝经后骨质疏松症或低骨密度女性中的安全性：一项荟萃分析。
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2113-22. eCollection 2014.
9
New roles of osteoblasts involved in osteoclast differentiation.成骨细胞在破骨细胞分化中的新作用。
World J Orthop. 2012 Nov 18;3(11):175-81. doi: 10.5312/wjo.v3.i11.175.
10
The pathogenesis, treatment and prevention of osteoporosis in men.男性骨质疏松症的发病机制、治疗和预防。
Drugs. 2013 Jan;73(1):15-29. doi: 10.1007/s40265-012-0003-1.
Zotero 插件